Ozempic maker's lawsuit, FDA enforcement could curtail sales of less expensive, compounded, versions of popular weight loss ...
NeoGenomics announced the launch of RaDaR® ST, its circulating tumor DNA assay for detecting molecular residual disease.
The U.S. Food and Drug Administration (FDA) has granted traditional approval to Braftovi (encorafenib) for adult patients ...
If you teach English learners, you already know the daily puzzle: a classroom full of students at five or six different ...
Artisan International Explorer Fund portfolio fell 0.55% during the quarter (advisor class), while our benchmark rose 2.96%. Read more here.
Survey Will Cover 100% of the Project and Support Structural Interpretation and Target Refinement Following Recent High-Grade ...
Although not as essential as in other tumor types, genomic testing is increasingly playing a role in guiding treatment for ...
The rise of the grooming gangs in Great Britain and the refusal of Britain’s Labor government to intervene speaks volumes about the contempt that British ...
Caris received FDA approval in November 2024 for MI Cancer Seek, a tissue-based assay that is the first and nly simultaneous ...
AutoChamber™ and AutoBMD™ AI solutions will soon be available on Precision Imaging Network, with AI-CVD® planned next.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results